Publications


Neuroprotective effect of the group III mGlu receptor agonist ACPT-I after ischemic stroke in rats with essential hypertension. Helena Domin, Łukasz Przykaza, Ewa Kozniewska, Paweł M Boguszewski, Maria Śmiałowska
Progress in neuro-psychopharmacology & biological psychiatry, S0278-5846(17)30736-4 10.1016/j.pnpbp.2018.02.006
PMID:29438731

Saturday, 10 February 2018
Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis. P Kawalec, P Holko, P Moćko, A Pilc
Rheumatology international, 10.1007/s00296-017-3919-7
PMID:29285605

Thursday, 28 December 2017
Involvement of extracellular signal-regulated kinase (ERK) in the short and long-lasting antidepressant-like activity of NMDA receptor antagonists (zinc and Ro 25-6981) in the forced swim test in rats. Bartłomiej Pochwat, Anna Rafało-Ulińska, Helena Domin, Paulina Misztak, Gabriel Nowak, Bernadeta Szewczyk
Neuropharmacology, S0028-3908(17)30373-8 10.1016/j.neuropharm.2017.08.006
PMID:28802646

Wednesday, 9 August 2017
The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test. Agnieszka Pałucha-Poniewiera, Karolina Podkowa, Tomasz Lenda, Andrzej Pilc
Progress in neuro-psychopharmacology & biological psychiatry, S0278-5846(17)30220-8 10.1016/j.pnpbp.2017.06.022
PMID:28647535

Wednesday, 21 June 2017
Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats. Zofia Rogóż, Katarzyna Kamińska, Patrycja Pańczyszyn-Trzewik, Magdalena Sowa-Kućma
Pharmacological reports : PR, S1734-1140(16)30398-X 10.1016/j.pharep.2017.02.022
PMID:28624596

Sunday, 18 June 2017
Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant. Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, Paulina Misztak, Rafał R Jaeschke, Katherine Sendek, Krzysztof Styczeń, Wojciech Datka, Magdalena Koperny
Pharmacological reports : PR, S1734-1140(16)30361-9 10.1016/j.pharep.2017.01.030
PMID:28499187

Friday, 12 May 2017
Disease activity, quality of life, and indirect costs of ulcerative colitis in Poland. Paweł Kawalec, Ewa Stawowczyk, Małgorzata Mossakowska, Andrzej Pilc
Przeglad gastroenterologiczny, 10.5114/pg.2017.66324
PMID:28337239

Tuesday, 7 March 2017
Safety Profile of Biologic Drugs in the Treatment of Inflammatory Bowel Diseases: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. Paweł Moćko, Paweł Kawalec, Andrzej Pilc
Clinical drug investigation, 10.1007/s40261-016-0459-y
PMID:27599485

Thursday, 2 March 2017
Serotonin transporter and receptor ligands with antidepressant activity as neuroprotective and proapoptotic agents. Zdzislaw Chilmonczyk, Andrzej J Bojarski, Andrzej Pilc, Ingebrigt Sylte
Pharmacological reports : PR, S1734-1140(16)30162-1 10.1016/j.pharep.2017.01.011
PMID:28324844

Sunday, 22 January 2017
The Involvement of GABAB signaling in the Antipsychotic-like Action of the Novel Orthosteric Agonist of mGlu4 Receptor, LSP4-2022. Monika Wozniak, Francine Acher, Marcin Marciniak, Magdalena Lason-Tyburkiewicz, Piotr Gruca, Mariusz Papp, Andrzej Pilc, Joanna M Wieronska
Current neuropharmacology,
PMID:26769224

Tuesday, 17 January 2017